Healthcare Services

Metagenomics In Healthcare Market Size Outlook and Demand Growth Across 2026–2030

April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Metagenomics In Healthcare Market Over The 2026–2030 Period?

The metagenomics in healthcare market has observed rapid expansion in its size over recent years. It is anticipated to grow from $2.44 billion in 2025 to $2.87 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 17.8%. This historical growth is primarily attributable to several key factors, including advancements in sequencing technologies, an increased incidence of infectious diseases, the expansion of microbiome research programs, a rising demand for culture-independent diagnostics, and the availability of clinical-grade sequencing workflows.

The metagenomics in healthcare market size is projected to experience swift expansion in the coming years. Its value is anticipated to reach $5.46 billion by 2030, driven by a compound annual growth rate (CAGR) of 17.5%. This growth throughout the forecast period is primarily attributed to the increasing adoption of precision infectious disease diagnostics, rising investments in microbiome therapeutics, the expansion of genomic epidemiology initiatives, the growing integration of AI in microbial analysis, and an increasing focus on personalized treatment strategies. Furthermore, significant trends for this period encompass the increasing adoption of metagenomic diagnostics in clinical settings, the growing use of microbiome-based disease profiling, the rising integration of NGS in infection management, the expansion of personalized microbial therapeutics research, and an enhanced focus on rapid pathogen identification.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28267&type=smp

What Underlying Factors Are Accelerating The Growth Of The Metagenomics In Healthcare Market?

The future expansion of the metagenomics in healthcare market is anticipated to be significantly propelled by the rising incidence of infectious diseases. These illnesses, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, can spread directly or indirectly between people. The growing prevalence of such diseases is largely attributed to increased global travel, which facilitates the rapid cross-border dissemination of pathogens. Metagenomics in healthcare plays a crucial role in tackling infectious diseases by enabling the quick and precise identification of pathogens, which is vital for controlling outbreaks. It also reduces diagnostic uncertainty through the analysis of complex microbial communities, thereby improving patient outcomes and guiding targeted treatments. For instance, in February 2024, the UK Health Security Agency, a UK-based government agency, reported that tuberculosis (a contagious bacterial infection that primarily affects the lungs) cases in England increased to 4,850 in 2023, representing a 10.7% rise from 4,380 cases in 2022. This increasing prevalence of infectious diseases is thus a key driver for the growth of the metagenomics in healthcare market.

How Is The Metagenomics In Healthcare Market Segmented Across Key Categories?

The metagenomics in healthcare market covered in this report is segmented –

1) By Types: Sample Extraction Kits, Metagenomics Kits

2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray

3) By Workflow: Sample Collection, Deoxyribonucleic Acid Extraction, Library Preparation, Sequencing

4) By Application: Infectious Disease Diagnosis, Genomic Epidemiology, Personalized Medicine, Microbiome Analysis, Drug Discovery

5) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies

Subsegments:

1) By Sample Extraction Kits: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Protein Extraction Kits

2) By Metagenomics Kits: Library Preparation Kits, Sequencing Kits, Target Enrichment Kits

How Are Trends Transforming The Metagenomics In Healthcare Market Landscape?

Key companies active in the metagenomics in healthcare market are prioritizing the creation of innovative solutions, such as microbial community profiling, to improve disease diagnosis, enable tailored treatments, and push forward precision medicine. Microbial community profiling entails the thorough examination and description of various microbial groups within a specific setting or sample, employing sequencing and bioinformatics tools to ascertain their makeup, variety, and functional contributions. For example, in August 2024, MGI Tech Co. Ltd., a China-based biotechnology company, unveiled a Human Microbiome Metagenomics Sequencing Package to further microbial research and healthcare applications. This package offers an automated, comprehensive microbial community profiling workflow for effectively analyzing human microbiome diversity, function, and links to diseases using proven high-throughput platforms. It reduces manual effort, boosts consistency, and lowers expenditures, thereby making large-scale and clinical microbiome research more widely available. Researchers benefit from rapid and accurate microbial identification, alongside flexible throughput, which supports biomarker discovery and advances translational health research.

Who Are The Dominant Players Shaping The Metagenomics In Healthcare Market Landscape?

Major companies operating in the metagenomics in healthcare market are F. Hoffmann-La Roche AG, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Novogene Corporation, Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., MedGenome Labs Limited, Zymo Research Corporation, BaseClear B.V., Psomagen Inc., Karius Inc., Microsynth AG, Macrogen Inc., Norgen Biotek Corp., Tiny Health Inc., CosmosID Inc., Kanvas Biosciences Inc., Phase Genomics Inc., Wobble Genomics Inc.

Read the full metagenomics in healthcare market report here:

https://www.thebusinessresearchcompany.com/report/metagenomics-in-healthcare-global-market-report

Which Region Is Projected To Dominate The Metagenomics In Healthcare Market During The Forecast Period?

North America was the largest region in the metagenomics in healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Metagenomics In Healthcare Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28267&type=smp

Browse Through More Reports Similar to the Global Metagenomics In Healthcare Market 2026, By The Business Research Company

Metagenomic Sequencing Global Market Report

https://www.thebusinessresearchcompany.com/report/metagenomic-sequencing-global-market-report

Metabolomics Global Market Report

https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report

Genomics In Cancer Care Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795